Description
This product is a human monoclonal IgG1 antibody targeting sialyl-Lewis(a) (sLea), an epitope present on the CA19-9 cancer antigen. On the basis of the potential of sLea as a target for immune attack and their affinity, specificity, and effector functions, this antibody has clinical utility in the treatment of cancer.
Target
CA19-9
Target Alias Names
CA19-9, Human CA19-9
Isotype/Mimetic
Human IgG1
Animal-Derived Biomaterials Used
None
Sequence Available
No
Original Discovery Method
Human-derived phage display
Original Discovery Information Provided On Datasheet
No
Antibody/Binder Origins
Animal-free discovery, In vitro recombinant expression